Fig 23 - by Zhezhe Zhang (19704587)

Subjects:

Stress path diagram of Ⅱ, Ⅲ and Ⅳ groups of specimens. by Zhezhe Zhang (19704587)

Subjects:

CONSORT 2025 Flow Diagram [70]. by Robert Trybulski (10998702)

Subjects:

Basic mechanical parameters of concrete specimens. by Zhezhe Zhang (19704587)

Subjects:

Fig 19 - by Zhezhe Zhang (19704587)

Subjects:

Fig 8 - by Zhezhe Zhang (19704587)

Subjects:

Percentage reduction of shear strength parameters. by Zhezhe Zhang (19704587)

Subjects:

Relationship between τ_<i>i</i> and σ_<i>i</i>. by Zhezhe Zhang (19704587)

Subjects:

Adverse event list. by Stefan Halbherr (21353882)

“…No statistically significant improvements were seen in the Montreal Cognitive Assessment (MoCA) (mean decrease −0.73; 95% CI; −2.1, 0.62; <i>p</i> = 0.255), Epworth Sleepiness Scale (mean increase 0.09; 95% CI; −2.6, 2.8; <i>p</i> > 0.999), Beck Depression Inventory (BDI) (mean decrease −1.27; 95% CI; −3.8, 1.3; <i>p</i> = 0.257), and the Starkstein Apathy Scale (mean increase 0.36; 95% CI; −1.6, 2.4; <i>p</i> = 0.822). …”

Patient characteristics. by Stefan Halbherr (21353882)

“…No statistically significant improvements were seen in the Montreal Cognitive Assessment (MoCA) (mean decrease −0.73; 95% CI; −2.1, 0.62; <i>p</i> = 0.255), Epworth Sleepiness Scale (mean increase 0.09; 95% CI; −2.6, 2.8; <i>p</i> > 0.999), Beck Depression Inventory (BDI) (mean decrease −1.27; 95% CI; −3.8, 1.3; <i>p</i> = 0.257), and the Starkstein Apathy Scale (mean increase 0.36; 95% CI; −1.6, 2.4; <i>p</i> = 0.822). …”

Effects of finerenone on the UACR in all patients. by Jia Song (495396)

Subjects:

Changes in blood pressure, HbA1c, blood lipid and liver function-related indicator values compared with baseline values in all patients over time. by Jia Song (495396)

Subjects:

Changes in blood pressure, HbA1c, blood lipids and liver function-related indicator values from 3 months to 6 months of treatment in all patients. by Jia Song (495396)

Subjects:

Changes in the UACR and urinary β2-MG levels compared with baseline values over time. by Jia Song (495396)

Subjects:

Changes in the eGFRs and serum potassium levels compared with baseline values in all patients over time. by Jia Song (495396)

Subjects:

Comparison of the rates of decline in the UACR and urinary β2-MG levels between the two subgroups. by Jia Song (495396)

Subjects:

Changes in the eGFRs and serum potassium levels compared with values at the end of 1 month of treatment in all patients over time. by Jia Song (495396)

Subjects:

Changes in inflammatory cytokine levels compared with baseline values in all patients over time. by Jia Song (495396)

Subjects:

Effects of finerenone on the urinary β2-MG levels in all patients. by Jia Song (495396)

Subjects:

Fig 4 - by Takafumi Kabuto (14797727)

Subjects: